| Name: | Travere Therapeutics, Inc. |
| Jurisdiction: | Alaska |
| Legal type: | Business Corporation |
| Status: | Good Standing |
| Date of registration: | 10 Jan 2023 (2 years ago) |
| Entity Number: | 10219599 |
| Place of Formation: | DELAWARE |
| Address: | 3611 VALLEY CENTRE DRIVE, SUITE 300, SAN DIEGO, CA 92130 |
Line of Business
31-33 ManufacturingNAICS
325412 PHARMACEUTICAL PREPARATION MANUFACTURING| Name | Role |
|---|---|
| The Vanguard Group, Inc. | Shareholder |
| Deep Track Capital, LP | Shareholder |
| Gary Lyons | Director |
| Jeffrey Meckler | Director |
| Sandra Poole | Director |
| Elizabeth E. Reed | Secretary |
| Ron Squarer | Director |
| Ruth Williams-Brinkley | Director |
| Armistice Capital, LLC | Shareholder |
| RA Capital Management L.P. | Shareholder |
| License Number | Type | Status | Issue Date | Date of renewal | Expiration date | Description |
|---|---|---|---|---|---|---|
| 2172596 | Business License | Active | 2023-01-10 | - | 2024-12-31 | LOB: 31-33 - Manufacturing, NAICS: 325412 - PHARMACEUTICAL PREPARATION MANUFACTURING |
Date of last update: 24 Jan 2025
Sources: State of Alaska - Department of Commerce, Community, and Economic Development
